The historical rank and industry rank for Third Harmonic Bio's Net Margin % or its related term are showing as below:
THRD's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.15 * Ranked among companies with meaningful Net Margin % only.
Third Harmonic Bio Net Margin % Historical Data
The historical data trend for Third Harmonic Bio's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Third Harmonic Bio's Net Margin %
For the Biotechnology subindustry, Third Harmonic Bio's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Third Harmonic Bio's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Third Harmonic Bio's Net Margin % distribution charts can be found below:
* The bar in red indicates where Third Harmonic Bio's Net Margin % falls into.
Third Harmonic Bio Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Third Harmonic Bio's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Third Harmonic Bio (NAS:THRD) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Third Harmonic Bio Net Margin % Related Terms
Thank you for viewing the detailed overview of Third Harmonic Bio's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Third Harmonic Bio (Third Harmonic Bio) Business Description
Third Harmonic Bio Inc is a clinical-stage company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases.. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
THRD has been successfully added to your 